Literature DB >> 6221835

T lymphocyte sensitization and suppressor T lymphocyte defect in patients long after treatment for Graves' disease.

J How, D J Topliss, C Strakosch, M Lewis, V V Row, R Volpé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6221835     DOI： 10.1111/j.1365-2265.1983.tb03187.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  4 in total

1.  Studies on the immunoregulation of thyroid autoantibody production in vitro.

Authors:  P Benveniste; V V Row; R Volpé
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

Review 2.  Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?

Authors:  L Bartalena; C Marcocci; A Lai; M L Tanda
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

3.  Mechanism and significance of abnormal blood level of beta 2-microglobulin in patients with Graves' disease.

Authors:  X L Han; W X Yie
Journal:  J Tongji Med Univ       Date:  1988

4.  Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.

Authors:  J R Baker; Y G Lukes; R C Smallridge; M Berger; K D Burman
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.